APLLTD.NS实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (6 May 2024 @ 18:00):

Alembic Pharmaceuticals Limited develops, manufactures, and markets pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients and formulations...

Stats
今日成交量	163 853
平均成交量	143 798
市值	201.30B
EPS	INR0 ( 2024-04-04 )
下一个收益日期	( INR6.90 ) 2024-05-08
Last Dividend	INR8.00 ( 2023-07-28 )
Next Dividend	INR0 ( N/A )
P/E	34.13
ATR14	INR1.563 (0.15%)

音量相关性

長: -0.21 (neutral)

短: -0.17 (neutral)

Signal:(54.003) Neutral

Alembic Pharmaceuticals 相关性

10 最正相关
KRITIKA.NS	0.931
ICICIPHARM.NS	0.93
KOPRAN.NS	0.929
NAVNETEDUL.NS	0.923
MUTHOOTFIN.NS	0.921
STAR.NS	0.919
FAIRCHEMOR.NS	0.912
KCP.NS	0.908
AARTISURF.NS	0.907
20MICRONS.NS	0.907

10 最负相关
LTGILTBEES.NS	-0.938
4THDIM.NS	-0.936
RAJRILTD.NS	-0.93
JSL.NS	-0.893
ACI.NS	-0.864
GNA.NS	-0.858
SYMPHONY.NS	-0.853
ISMTLTD.NS	-0.849
DFMFOODS.NS	-0.834
GTNIND.NS	-0.817

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Alembic Pharmaceuticals 相关性 - 货币/商品

-0.39
( neutral )

-0.29
( neutral )

-0.86
( strong negative )

-0.28
( neutral )

0.36
( neutral )

0.70
( moderate )

Alembic Pharmaceuticals 财务报表

Annual	2022
营收:	INR56.53B
毛利润:	INR39.44B (69.77 %)
EPS:	INR17.40

FY	2022
营收:	INR56.53B
毛利润:	INR39.44B (69.77 %)
EPS:	INR17.40

FY	2022
营收:	INR52.32B
毛利润:	INR35.09B (67.06 %)
EPS:	INR26.50

FY	2021
营收:	INR53.01B
毛利润:	INR37.80B (71.30 %)
EPS:	INR60.81

Financial Reports:

No articles found.

Alembic Pharmaceuticals Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR10.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR8.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Alembic Pharmaceuticals Dividend Information - Dividend Junior

Dividend Sustainability Score: 3.28 - low (9.11%) | Divividend Growth Potential Score: 3.88 - Decrease likely (22.35%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR1.400	2012-07-31
Last Dividend	INR8.00	2023-07-28
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	12	--
Total Paid Out	INR62.90	--
Avg. Dividend % Per Year	0.84%	--
Score	2.03	--
Div. Sustainability Score	3.28
Div.Growth Potential Score	3.88
Div. Directional Score	3.58	--

Next Divdend (Est)
(2024-06-27)

INR8.06 Estimate 3.11 %

Dividend Stability

0.25 Very Poor

Dividend Score

2.03

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2012	INR0	0.00%
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR4.00	0.79%
2019	INR5.50	0.94%
2020	INR3.00	0.55%
2021	INR14.00	1.34%
2022	INR10.00	1.24%
2023	INR8.00	1.41%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
RAYMOND.NS	Dividend Junior	2023-06-23	Sporadic	29	0.15%
KOTARISUG.NS	Dividend Junior	2023-08-03	Sporadic	11	0.58%
EVERESTIND.NS	Dividend Junior	2023-08-14	Annually	22	0.75%
AMBIKCO.NS	Dividend Junior	2023-09-22	Annually	17	1.61%
SYRMA.NS	No Dividend Player	2023-09-01	Insufficient data to determine frequency	2	0.18%
NEWGEN.NS	Dividend Knight	2023-06-20	Annually	7	2.26%
IFGLEXPOR.NS	Dividend Junior	2023-08-17	Annually	21	1.57%
CHAMBLFERT.NS	Dividend Junior	2023-08-21	Annually	23	1.58%
SAGCEM.NS	Dividend Junior	2023-06-20	Annually	18	0.28%
LTIM.NS	Dividend Knight	2023-07-10	Semi-Annually	9	0.87%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0965	1.500	8.07	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.134	1.500	9.63	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	10.28	1.000	7.30	7.30	[3 - 30]
operatingCashFlowPerShareTTM	28.22	2.00	0.595	1.189	[0 - 30]
freeCashFlowPerShareTTM	28.22	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.711	1.000	1.484	1.484	[0.2 - 0.8]
operatingProfitMarginTTM	0.100	1.000	10.00	10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				3.28

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	33.88	1.000	6.68	0	[1 - 100]
returnOnEquityTTM	0.134	2.50	9.76	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	28.22	2.00	0.595	10.00	[0 - 30]
dividendYielPercentageTTM	0.787	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	28.22	2.00	0.595	1.189	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.647	1.500	9.02	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0907	1.000	-0.234	0	[0.1 - 0.5]
Total Score				3.88

Alembic Pharmaceuticals

Alembic Pharmaceuticals Limited develops, manufactures, and markets pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients and formulations. The company also provides branded and generic formulations in various therapeutic areas, such as cardiology, gynecology, gastrology, ophthalmology, dermatology, nephrology/urology, orthopedics, anti-infective, cold and cough, and anti-diabetic. In addition, it exports its products. Alembic Pharmaceuticals Limited was founded in 1907 and is headquartered in Vadodara, India.

实时更新： Alembic Pharmaceuticals [APLLTD.NS]

Upcoming Earnings Alert

Alembic Pharmaceuticals Dividend Information - Dividend Junior

Dividend Commentary

Top 10 dividend Companies for NSE

Dividend Sustainability Score (DSS)

Dividend Growth Score (DGS)